Literature DB >> 8038265

The structure, function and turnover of aggrecan, the large aggregating proteoglycan from cartilage.

T E Hardingham1, A J Fosang, J Dudhia.   

Abstract

Aggrecan, the large aggregating proteoglycan from cartilage contains chondroitin sulphate and keratan sulphate attached to a multidomain protein core. It aggregates by binding to hyaluronan and this is further stabilised by a separate globular link protein. There are two structurally related N-terminal globular domains, G1 and G2, of which only G1 and not G2 is involved in aggregation. The interglobular domain joining G1 and G2 contains proteinase sensitive sequences which appear to be the key site for cleavage during aggrecan turnover. Much of the keratan sulphate and all of the chondroitin sulphate is attached to the long extended glycosaminoglycan attachment region. The function of the C-terminal G3 domain is unknown. It contains a mammalian type C lectin and complement regulatory protein motifs. These may have interactive properties that contribute to matrix organisation. There is also an alternatively spliced form with an epidermal growth factor-like motif. The carbohydrate composition of aggrecan varies with cartilage source, development and age and is heterogeneous in each sample. There is evidence of a close control of chondroitin sulphate synthesis that determines chain length and disaccharide composition and which change during development and in pathology. Monoclonal antibodies that recognise specific sequences within chondroitin sulphate chains enable some of these changes in fine structure to be detected. Progressive digestion of chains with chondroitinase AC II has provided evidence of a pattern of sulphation, with 6-sulphated disaccharides more abundant towards the protein core, although the disaccharide next to the linkage region is predominantly non-sulphated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8038265

Source DB:  PubMed          Journal:  Eur J Clin Chem Clin Biochem        ISSN: 0939-4974


  14 in total

1.  The effects of osmotic stress on the viscoelastic and physical properties of articular chondrocytes.

Authors:  Farshid Guilak; Geoffrey R Erickson; H Ping Ting-Beall
Journal:  Biophys J       Date:  2002-02       Impact factor: 4.033

2.  Analysis of lapine cartilage matrix after radiosynovectomy with holmium-166 ferric hydroxide macroaggregate.

Authors:  O T Mäkelä; M J Lammi; H Uusitalo; M M Hyttinen; E Vuorio; H J Helminen; R-M Tulamo
Journal:  Ann Rheum Dis       Date:  2003-01       Impact factor: 19.103

3.  Species-specific alternative splicing of the epidermal growth factor-like domain 1 of cartilage aggrecan.

Authors:  C Fülöp; G Cs-Szabó; T T Glant
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

Review 4.  Consequences of metabolic and oxidative modifications of cartilage tissue.

Authors:  John A Hardin; Neil Cobelli; Laura Santambrogio
Journal:  Nat Rev Rheumatol       Date:  2015-06-02       Impact factor: 20.543

5.  MMPs are less efficient than ADAMTS5 in cleaving aggrecan core protein.

Authors:  Michaela Durigova; Hideaki Nagase; John S Mort; Peter J Roughley
Journal:  Matrix Biol       Date:  2010-11-03       Impact factor: 11.583

Review 6.  Cartilage biology, pathology, and repair.

Authors:  Daniel Umlauf; Svetlana Frank; Thomas Pap; Jessica Bertrand
Journal:  Cell Mol Life Sci       Date:  2010-08-25       Impact factor: 9.261

7.  Aggrecan: A Target Molecule of Autoimmune Reactions.

Authors:  Edit I Buzás; Katalin Mikecz; Tibor T Glant
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

8.  Human link protein gene: structure and transcription pattern in chondrocytes.

Authors:  J Dudhia; M T Bayliss; T E Hardingham
Journal:  Biochem J       Date:  1994-10-01       Impact factor: 3.857

9.  Age-related changes in the content of the C-terminal region of aggrecan in human articular cartilage.

Authors:  J Dudhia; C M Davidson; T M Wells; D H Vynios; T E Hardingham; M T Bayliss
Journal:  Biochem J       Date:  1996-02-01       Impact factor: 3.857

10.  Expression of glycosaminoglycan epitopes during zebrafish skeletogenesis.

Authors:  Anthony J Hayes; Ruth E Mitchell; Andrew Bashford; Scott Reynolds; Bruce Caterson; Chrissy L Hammond
Journal:  Dev Dyn       Date:  2013-04-29       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.